Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

159.16
-5.9700-3.62%
Post-market: 159.160.00000.00%18:03 EDT
Volume:814.24K
Turnover:129.35M
Market Cap:7.83B
PE:-54.65
High:163.60
Open:163.60
Low:153.25
Close:165.13
52wk High:228.88
52wk Low:91.86
Shares:49.22M
Float Shares:48.62M
Volume Ratio:0.94
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9122
EPS(LYR):-2.9122
ROE:-4.23%
ROA:4.24%
PB:2.48
PE(LYR):-54.65

Loading ...

Charles River Laboratories International- Seasonality During Holiday Periods in Q4 and in Early Jan May Impact Near-Term Proposal, Booking Activity

THOMSON REUTERS
·
Dec 03, 2025

Charles River Laboratories Presents at Evercore 8th Annual Healthcare Conference

Reuters
·
Dec 03, 2025

Jefferies Adjusts PT on Charles River Laboratories International to $205 From $200, Maintains Buy Rating

MT Newswires Live
·
Dec 02, 2025

U.S. RESEARCH ROUNDUP- Green Brick Partners, Pultegroup, Toll Brothers

Reuters
·
Dec 02, 2025

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Dec 02, 2025

Charles River Laboratories to Present at Evercore Healthcare Conference

Reuters
·
Dec 01, 2025

Charles River Laboratories International Inc. Stock Rises 4.5%, Outperforms Peers

Dow Jones
·
Nov 26, 2025

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 22, 2025

Charles River Q3 Adjusted EPS USD 2.43 Vs. IBES Estimate USD 2.34

Reuters
·
Nov 20, 2025

Charles River Exec Says Co Is Looking to Expand Its Services Portfolio in China - Jefferies Healthcare Conf

THOMSON REUTERS
·
Nov 18, 2025

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Nov 18, 2025

Argus Upgrades Charles River Laboratories International to Buy From Hold, Price Target is $200

MT Newswires Live
·
Nov 17, 2025

Charles River: SEC concluded inquiry into company, not recommeding enforcement

TIPRANKS
·
Nov 17, 2025

SEC Ends Probe Into Charles River Laboratories With No Enforcement Action

Reuters
·
Nov 17, 2025

Charles River Laboratories-Investigation Was About Inquiry Requesting to Give Information Related to Sourcing Non-Human Primates & Related Disclosures

THOMSON REUTERS
·
Nov 17, 2025

Charles River Laboratories International Inc - SEC Concludes Investigation, No Action Against Charles River Labs - SEC Filing

THOMSON REUTERS
·
Nov 17, 2025

Charles River Laboratories Presents at Jefferies Global Healthcare Conference

Reuters
·
Nov 17, 2025

Charles River Laboratories International Inc : Argus Research Raises to Buy From Hold

THOMSON REUTERS
·
Nov 17, 2025

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Nov 14, 2025

Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD

GlobeNewswire
·
Nov 13, 2025